Role for proteases and HLA-G in the pathogenicity of influenza A viruses

Journal of Clinical Virology

Volumn 51, Issue 3, 2011, Pages 155-159

  Foucault, Marie Laure ^a   Moules, Vincent ^a   Rosa Calatrava, Manuel ^a   Riteau, Béatrice ^a,b  

^a UNIVERSITÉ LYON 1   (France)

^b CEMAGREF   (France)

Author keywords

HLA G; Host virus relation; Inflammation; Influenza virus; Proteases activated receptors; Therapeutic

Indexed keywords

HEMAGGLUTININ; HLA G ANTIGEN; LIPOCORTIN 2; PLASMINOGEN; PROTEINASE; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; VIRUS RECEPTOR;

HOST RESISTANCE; HUMAN; IMMUNOMODULATION; INFLUENZA A; INFLUENZA VIRUS A; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; REVIEW; TROPISM; VIRUS CELL INTERACTION; VIRUS REPLICATION;

HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNE TOLERANCE; INFLUENZA A VIRUS; INFLUENZA, HUMAN; PEPTIDE HYDROLASES;

EID: 79959269153     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.04.013     Document Type: Review

References (89)

1. Kilbourne E.D. Influenza pandemics of the 20th century. Emerg Infect Dis 2006, 12:9-14.
2. Lewis D.B. Avian flu to human influenza. Annu Rev Med 2006, 57:139-154.
3. Peiris J.S., Poon L.L., Guan Y. Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol 2009, 45:169-173.
4. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009, 360:2605-2615.
5. Sullivan S.J., Jacobson R.M., Dowdle W.R., Poland G.A. H1N1 influenza. Mayo Clin Proc 2009, 85:64-76.
6. Rogers G.N., Paulson J.C., Daniels R.S., Skehel J.J., Wilson I.A., Wiley D.C. Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature 1983, 304:76-78.
7. Matrosovich M.N., Matrosovich T.Y., Gray T., Roberts N.A., Klenk H.D. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci USA 2004, 101:4620-4624.
8. van Riel D., Munster V.J., de Wit E., Rimmelzwaan G.F., Fouchier R.A., Osterhaus A.D., et al. H5N1 virus attachment to lower respiratory tract. Science 2006, 312:399.
9. Senne D.A., Panigrahy B., Kawaoka Y., Pearson J.E., Süss J., Lipkind M., et al. Survey of the hemagglutinin (HA) cleavage site sequence of H5 and H7 avian influenza viruses: amino acid sequence at the HA cleavage site as a marker of pathogenicity potential. Avian Dis 1996, 40:425-437.
10. Peiris J.S., de Jong M.D., Guan Y. Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev 2007, 20:243-267.
11. Okumura Y., Takahashi E., Yano M., Ohuchi M., Daidoji T., Nakaya T., et al. Novel type II transmembrane serine proteases, MSPL and TMPRSS13, proteolytically activate membrane fusion activity of the hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication. J Virol 2010, 84:5089-5096.
12. Kido H., Yokogoshi Y., Sakai K., Tashiro M., Kishino Y., Fukutomi A., et al. Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein. J Biol Chem 1992, 267:13573-13579.
13. LeBouder F., Morello E., Rimmelzwaan G.F., Bosse F., Péchoux C., Delmas B., et al. Annexin II incorporated into influenza virus particles supports virus replication by converting plasminogen into plasmin. J Virol 2008, 82:6820-6828.
14. Bottcher E., Matrosovich T., Beyerle M., Klenk H.D., Garten W., Matrosovich M. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J Virol 2006, 80:9896-9898.
15. Yamaoka K., Masuda K., Ogawa H., Takagi K., Umemoto N., Yasuoka S. Cloning and characterization of the cDNA for human airway trypsin-like protease. J Biol Chem 1998, 273:11895-11901.
16. Bottcher E., Freuer C., Steinmetzer T., Klenk H.D., Garten W. MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition. Vaccine 2009, 27:6324-6329.
17. Tashiro M., Ciborowski P., Klenk H.D., Pulverer G., Rott R. Role of Staphylococcus protease in the development of influenza pneumonia. Nature 1987, 325:536-537.
18. Tashiro M., Ciborowski P., Reinacher M., Pulverer G., Klenk HD., Rott R. Synergistic role of staphylococcal proteases in the induction of influenza virus pathogenicity. Virology 1987, 157:421-430.
19. Zhirnov O.P., Ikizler M.R., Wright P.F. Cleavage of influenza a virus hemagglutinin in human respiratory epithelium is cell associated and sensitive to exogenous antiproteases. J Virol 2002, 76:8682-8689.
20. Bertram S., Glowacka I., Blazejewska P., Soilleux E., Allen P., Danisch S., et al. TMPRSS2 and TMPRSS4 facilitate trypsin-independent influenza virus spread in Caco-2 cells. J Virol 2010, 84:10016-10025.
21. Chaipan C., Kobasa D., Bertram S., Glowacka I., Steffen I., Tsegaye T.S., et al. Proteolytic activation of the 1918 influenza virus hemagglutinin. J Virol 2009, 83:3200-3211.
22. Bertram S., Glowacka I., Steffen I., Kuhl A., Pohlmann S. Novel insights into proteolytic cleavage of influenza virus hemagglutinin. Rev Med Virol 2010, 20:298-310.
23. Partin J.C., Partin J.S., Schubert W.K., Jacobs R., Saalfeld K. Isolation of influenza virus from liver and muscle biopsy specimens from a surviving case of Reye's syndrome. Lancet 1976, 2:599-602.
24. Kessler H.A., Trenholme G.M., Harris A.A., Levin S. Acute myopathy associated with influenza A/Texas/1/77 infection. Isolation of virus from a muscle biopsy specimen. JAMA 1980, 243:461-462.
25. Cioc A.M., Nuovo G.J. Histologic and in situ viral findings in the myocardium in cases of sudden, unexpected death. Mod Pathol 2002, 15:914-922.
26. Takahashi M., Yamada T., Nakashita Y., Saikusa H., Deguchi M., Kida H., et al. Influenza virus-induced encephalopathy: clinicopathologic study of an autopsied case. Pediatr Int 2000, 42:204-214.
27. Munster V.J., Schrauwen E.J., de Wit E., van den Brand J.M., Bestebroer TM., Herfst S., et al. Insertion of a multibasic cleavage motif into the hemagglutinin of a low-pathogenic avian influenza H6N1 virus induces a highly pathogenic phenotype. J Virol 2010, 84:7953-7960.
28. Kuiken T., Taubenberger J.K. Pathology of human influenza revisited. Vaccine 2008, 26(Suppl. 4):D59-D66.
29. Zhao Y., Lu M., Lau L.T., Lu J., Gao Z., Liu J., et al. Neutrophils may be a vehicle for viral replication and dissemination in human H5N1 avian influenza. Clin Infect Dis 2008, 47:1575-1578.
30. Studahl M. Influenza virus and CNS manifestations. J Clin Virol 2003, 28:225-232.
31. Toovey S. Influenza-associated central nervous system dysfunction: a literature review. Travel Med Infect Dis 2008, 6:114-124.
32. Sano T. Influenza myocarditis and pericarditis. Nippon Rinsho 2006, 64:1916-1920.
33. Tsuruoka H., Xu H., Kuroda K., Hosaka Y. Viremia in influenza: detection by polymerase chain reaction. Nippon Rinsho 1997, 55:2714-2718.
34. Fislova T., Gocnik M., Sladkova T., Durmanová V., Rajcáni J., Varecková E., et al. Multiorgan distribution of human influenza A virus strains observed in a mouse model. Arch Virol 2009, 154:409-419.
35. Goto H., Kawaoka Y. A novel mechanism for the acquisition of virulence by a human influenza A virus. Proc Natl Acad Sci USA 1998, 95:10224-10228.
36. Goto H., Wells K., Takada A., Kawaoka Y. Plasminogen-binding activity of neuraminidase determines the pathogenicity of influenza A virus. J Virol 2001, 75:9297-9301.
37. Ollier L., Caramella A., Giordanengo V., Lefebvre J.C. High permissivity of human HepG2 hepatoma cells for influenza viruses. J Clin Microbiol 2004, 42:5861-5865.
38. Hajjar K.A., Krishnan S. Annexin II: a mediator of the plasmin/plasminogen activator system. Trends Cardiovasc Med 1999, 9:128-138.
39. Lebouder F., Lina B., Rimmelzwaan G.F., Riteau B. Plasminogen promotes influenza A virus replication through an annexin 2-dependent pathway in the absence of neuraminidase. J Gen Virol 2010, 91:2753-2761.
40. Shaw M.L., Stone K.L., Colangelo C.M., Gulcicek E.E., Palese P. Cellular proteins in influenza virus particles. PLoS Pathog 2008, 4:e1000085.
41. Rescher U., Gerke V. Annexins-unique membrane binding proteins with diverse functions. J Cell Sci 2004, 117:2631-2639.
42. Polakos N.K., Cornejo J.C., Murray D.A., Wright K.O., Treanor J.J., Crispe I.N., et al. Kupffer cell-dependent hepatitis occurs during influenza infection. Am J Pathol 2006, 168:1169-1178. [quiz 404-5].
43. Riteau B., de Vaureix C., Lefevre F. Trypsin increases pseudorabies virus production through activation of the ERK signalling pathway. J Gen Virol 2006, 87:1109-1112.
44. Chignard M., Pidard D. Neutrophil and pathogen proteinases versus proteinase-activated receptor-2 lung epithelial cells: more terminators than activators. Am J Respir Cell Mol Biol 2006, 34:394-398.
45. Shpacovitch V., Feld M., Hollenberg M.D., Luger T.A., Steinhoff M. Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity. J Leukoc Biol 2008, 83:1309-1322.
46. Hollenberg M.D. Proteinase-mediated signaling: proteinase-activated receptors (PARs) and much more. Life Sci 2003, 74:237-246.
47. Cocks T.M., Moffatt J.D. Protease-activated receptor-2 (PAR2) in the airways. Pulm Pharmacol Ther 2001, 14:183-191.
48. de Jong M.D., Simmons C.P., Thanh T.T., Hien V.M., Smith G.J., Chau T.N., et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006, 12:1203-1207.
49. Cocks T.M., Fong B., Chow J.M., Anderson G.P., Frauman A.G., Goldie R.G., et al. A protective role for protease-activated receptors in the airways. Nature 1999, 398:156-160.
50. Dulon S., Cande C., Bunnett N.W., Hollenberg MD., Chignard M., Pidard D. Proteinase-activated receptor-2 and human lung epithelial cells: disarming by neutrophil serine proteinases. Am J Respir Cell Mol Biol 2003, 28:339-346.
51. Ebeling C., Lam T., Gordon J.R., Hollenberg M.D., Vliagoftis H. Proteinase-activated receptor-2 promotes allergic sensitization to an inhaled antigen through a TNF-mediated pathway. J Immunol 2007, 179:2910-2917.
52. Feld M., Shpacovitch V.M., Ehrhardt C., Kerkhoff C., Hollenberg M.D., Vergnolle N., et al. Agonists of proteinase-activated receptor-2 enhance IFN-gamma-inducible effects on human monocytes: role in influenza A infection. J Immunol 2008, 180:6903-6910.
53. Khoufache K., LeBouder F., Morello E., Laurent F., Riffault S., Andrade-Gordon P., et al. Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway. J Immunol 2009, 182:7795-7802.
54. Moraes T.J., Martin R., Plumb J.D., Vachon E., Cameron C.M., Danesh A., et al. Role of PAR2 in murine pulmonary pseudomonal infection. Am J Physiol Lung Cell Mol Physiol 2008, 294:L368-L377.
55. Ostrowska E., Sokolova E., Reiser G. PAR-2 activation and LPS synergistically enhance inflammatory signaling in airway epithelial cells by raising PAR expression level and interleukin-8 release. Am J Physiol Lung Cell Mol Physiol 2007, 293:L1208-L1218.
56. Lan R.S., Stewart G.A., Goldie R.G., Henry P.J. Altered expression and in vivo lung function of protease-activated receptors during influenza A virus infection in mice. Am J Physiol Lung Cell Mol Physiol 2004, 286:L388-L398.
57. Knight D.A., Lim S., Scaffidi A.K., Roche N., Chung K.F., Stewart G.A., et al. Protease-activated receptors in human airways: upregulation of PAR-2 in respiratory epithelium from patients with asthma. J Allergy Clin Immunol 2001, 108:797-803.
58. Cederqvist K., Haglund C., Heikkilä P., Hollenberg M.D., Karikoski R., Andersson S. High expression of pulmonary proteinase-activated receptor 2 in acute and chronic lung injury in preterm infants. Pediatr Res 2005, 57:831-836.
59. Nakano S., Mishiro T., Takahara S., Yokoi H., Hamada D., Yukata K., et al. Distinct expression of mast cell tryptase and protease activated receptor-2 in synovia of rheumatoid arthritis and osteoarthritis. Clin Rheumatol 2007, 26:1284-1292.
60. Nhu Q.M., Shirey K., Teijaro J.R., Farber D.L., Netzel-Arnett S., Antalis T.M., et al. Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo. Mucosal Immunol 2010, 3:29-39.
61. Girart M.V., Fuertes M.B., Domaica C.I., Rossi L.E., Zwirner N.W. Engagement of TLR3 TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12. J Immunol 2007, 179:3472-3479.
62. Le Goffic R., Balloy V., Lagranderie M., Alexopoulou L., Escriou N., Flavell R., et al. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog 2006, 2:e53.
63. Sutherland M.R., Friedman H.M., Pryzdial E.L. Thrombin enhances herpes simplex virus infection of cells involving protease-activated receptor 1. J Thromb Haemost 2007, 5:1055-1061.
64. Doherty P.C., Brown L.E., Kelso A., Thomas P.G. Immunity to avian influenza A viruses. Rev Sci Tech 2009, 28:175-185.
65. Doherty P.C., Christensen J.P. Accessing complexity: the dynamics of virus-specific T cell responses. Annu Rev Immunol 2000, 18:561-592.
66. Le Bourhis L., Martin E., Peguillet I., Guihot A., Froux N., Coré M., et al. Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol 2010, 11:701-708.
67. Boliar S., Chambers T.M. A new strategy of immune evasion by influenza A virus: inhibition of monocyte differentiation into dendritic cells. Vet Immunol Immunopathol 2010, 136:201-210.
68. Pascale F., Contreras V., Bonneau M., Courbet A., Chilmonczyk S., Bevilacqua C., et al. Plasmacytoid dendritic cells migrate in afferent skin lymph. J Immunol 2008, 180:5963-5972.
69. Mao H., Tu W., Liu Y., Qin G., Zheng J., Chan P.L., et al. Inhibition of human natural killer cell activity by influenza virions and hemagglutinin. J Virol 2010, 84:4148-4157.
70. Riteau B., Barber D.F., Long E.O. Vav1 phosphorylation is induced by beta2 integrin engagement on natural killer cells upstream of actin cytoskeleton and lipid raft reorganization. J Exp Med 2003, 198:469-474.
71. Garcia-Sastre A. Antiviral response in pandemic influenza viruses. Emerg Infect Dis 2006, 12:44-47.
72. Berkhoff E.G., Geelhoed-Mieras M.M., Verschuren E.J., van Baalen C.A., Gruters R.A., Fouchier R.A., et al. The loss of immunodominant epitopes affects interferon-gamma production and lytic activity of the human influenza virus-specific cytotoxic T lymphocyte response in vitro. Clin Exp Immunol 2007, 148:296-306.
73. Rimmelzwaan G.F., Berkhoff E.G., Nieuwkoop N.J., Smith D.J., Fouchier R.A., Osterhaus A.D. Full restoration of viral fitness by multiple compensatory co-mutations in the nucleoprotein of influenza A virus cytotoxic T-lymphocyte escape mutants. J Gen Virol 2005, 86:1801-1805.
74. Bernard D., Riteau B., Hansen J.D., Phillips R.B., Michel F., Boudinot P., et al. Costimulatory receptors in a teleost fish: typical CD28, elusive CTLA4. J Immunol 2006, 176:4191-4200.
75. Lafon M., Prehaud C., Megret F., Lafage M., Mouillot G., Roa M., et al. Modulation of HLA-G expression in human neural cells after neurotropic viral infections. J Virol 2005, 79:15226-15237.
76. Rouas-Freiss N., Khalil-Daher I., Riteau B., Menier C., Paul P., Dausset J., et al. The immunotolerance role of HLA-G. Semin Cancer Biol 1999, 9:3-12.
77. Riteau B., Moreau P., Menier C., Khalil-Daher I., Khosrotehrani K., Bras-Goncalves R., et al. Characterization of HLA-G1, -G2-G3, and -G4 isoforms transfected in a human melanoma cell line. Transplant Proc 2001, 33:2360-2364.
78. Riteau B., Menier C., Khalil-Daher I., Martinozzi S., Pla M., Dausset J., et al. HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition. Int Immunol 2001, 13:193-201.
79. Riteau B., Rouas-Freiss N., Menier C., Paul P., Dausset J., Carosella E.D. HLA-G2-G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol 2001, 166:5018-5026.
80. Le Gal F.A., Riteau B., Sedlik C., Khalil-Daher I., Menier C., Dausset J., et al. HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol 1999, 11:1351-1356.
81. Riteau B., Menier C., Khalil-Daher I., Sedlik C., Dausset J., Rouas-Freiss N., et al. HLA-G inhibits the allogeneic proliferative response. J Reprod Immunol 1999, 43:203-211.
82. Menier C., Riteau B., Dausset J., Carosella E.D., Rouas-Freiss N. HLA-G truncated isoforms can substitute for HLA-G1 in fetal survival. Hum Immunol 2000, 61:1118-1125.
83. Riteau B., Faure F., Menier C., Viel S., Carosella E.D., Amigorena S., et al. Exosomes bearing HLA-G are released by melanoma cells. Hum Immunol 2003, 64:1064-1072.
84. Adrian Cabestre F., Moreau P., Riteau B., Ibrahim E.C., Le Danff C., Dausset J., et al. HLA-G expression in human melanoma cells: protection from NK cytolysis. J Reprod Immunol 1999, 43:183-193.
85. Paul P., Rouas-Freiss N., Khalil-Daher I., Moreau P., Riteau B., Le Gal F.A., et al. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA 1998, 95:4510-4515.
86. LeBouder F., Khoufache K., Menier C., Mandouri Y., Keffous M., Lejal N., et al. Immunosuppressive HLA-G molecule is upregulated in alveolar epithelial cells after influenza A virus infection. Hum Immunol 2009, 70:1016-1019.
87. Lozano J.M., González R., Kindelán J.M., Rouas-Freiss N., Caballos R., Dausset J., et al. Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS 2002, 16:347-351.
88. Onno M., Pangault C., Le Friec G., Guilloux V., André P., Fauchet R. Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol 2000, 164:6426-6434.
89. Chen H.X., Chen B.G., Shi W.W., Zhen R., Xu D.P., Lin A., et al. Induction of cell surface human leukocyte antigen-G expression in pandemic H1N1 2009 and seasonal H1N1 influenza virus-infected patients. Hum Immunol 2011, 72:159-165.